Twelve weeks of follow-up is sufficient for the determination of sustained virologic response in patients treated with interferon alpha for chronic hepatitis C.

[1]  K. Reddy,et al.  Prognostic factors and early predictability of sustained viral response with peginterferon alfa-2a (40KD). , 2002, Journal of hepatology.

[2]  Dieter Häussinger,et al.  Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. , 2002, The New England journal of medicine.

[3]  M. Shiffman,et al.  Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis. , 2000, The New England journal of medicine.

[4]  J. Reichen,et al.  Peginterferon alfa-2a in patients with chronic hepatitis C. , 2000, The New England journal of medicine.

[5]  S. Zeuzem,et al.  Detection of residual hepatitis C virus RNA by transcription‐mediated amplification in patients with complete virologic response according to polymerase chain reaction–based assays , 2000, Hepatology.

[6]  Z. Goodman,et al.  Is an “à la carte” combination interferon alfa‐2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C? , 2000, Hepatology.

[7]  L. Sawyer,et al.  Clinical laboratory evaluation of a new sensitive and specific assay for qualitative detection of hepatitis C virus RNA in clinical specimens , 2000 .

[8]  O. Weiland,et al.  Long-term follow-up of chronic hepatitis C patients with sustained virological response to alpha-interferon. , 1999, Journal of hepatology.

[9]  F. Caroli-Bosc,et al.  Second Generation of the Automated Cobas Amplicor HCV Assay Improves Sensitivity of Hepatitis C Virus RNA Detection and Yields Results That Are More Clinically Relevant , 1999, Journal of Clinical Microbiology.

[10]  J. McHutchison,et al.  Combination therapy with interferon plus ribavirin for the initial treatment of chronic hepatitis C. , 1999, Seminars in liver disease.

[11]  G. Colucci,et al.  Multicenter Evaluation of the COBAS AMPLICOR HCV Assay, an Integrated PCR System for Rapid Detection of Hepatitis C Virus RNA in the Diagnostic Laboratory , 1998, Journal of Clinical Microbiology.

[12]  O. Weiland,et al.  Therapy of hepatitis C: Alpha interferon and ribavirin , 1997, Hepatology.

[13]  P. Marcellin,et al.  Long-Term Histologic Improvement and Loss of Detectable Intrahepatic HCV RNA in Patients with Chronic Hepatitis C and Sustained Response to Interferon- Therapy , 1997, Annals of Internal Medicine.

[14]  S. Zeuzem,et al.  Evaluation and comparison of different hepatitis C virus genotyping and serotyping assays. , 1997, Journal of hepatology.

[15]  Z. Loewy,et al.  COBAS AMPLICOR: fully automated RNA and DNA amplification and detection system for routine diagnostic PCR. , 1996, Clinical chemistry.

[16]  K. Beavis,et al.  Evaluation of automated COBAS AMPLICOR PCR system for detection of several infectious agents and its impact on laboratory management , 1996, Journal of clinical microbiology.

[17]  M A Gerber,et al.  The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. , 1992, The New England journal of medicine.

[18]  M. Onji,et al.  Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. , 1990, Proceedings of the National Academy of Sciences of the United States of America.